National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meetings, 46709-46710 [2021-17748]
Download as PDF
<![CDATA[
lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W108,
Rockville, Maryland 20850, 240–276–6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Program Project IV.
Date: November 2–3, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W120, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W120,
Rockville, Maryland 20850, 240–276–6457,
mh101v@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–11:
NCI Clinical and Translational Cancer
Research.
Date: November 9, 2021.
Time: 11:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W542, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Biman Chandra Paria,
Ph.D., Scientific Review Officer, Program
Coordination and Referral Branch, Division
of Extramural Activities, National Cancer
Institute, NIH, 9606 Medical Center Drive,
Room 7W542, Rockville, Maryland 20850,
240–276–6454, pariab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Exercise
and Nutrition Interventions to Improve
Cancer Treatment-Related Outcomes
(ENICTO) in Cancer Survivors Consortium
(U01–U24).
Date: November 10, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W618, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Mukesh Kumar, Ph.D.,
Scientific Review Officer, Research Program
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W618,
Rockville, Maryland 20850, 240–276–6611,
mukesh.kumar3@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Novel
Technologies for Global Health.
Date: November 10, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W114, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Jeffrey E. DeClue, Ph.D.,
Scientific Review Officer, Research
VerDate Sep<11>2014
17:28 Aug 18, 2021
Jkt 253001
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W114, Rockville, Maryland
20850, 240–276–6371, decluej@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Oncology
Co-Clinical Imaging Research Resources to
Encourage Consensus on Quantitative
Imaging Methods and Precision Medicine
(U24—Clinical Trial Optional).
Date: November 15, 2021.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W634, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Michael E. Lindquist,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W634, Rockville, Maryland 20850,
mike.lindquist@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Revision
Applications for Mechanisms of Cancer Drug
Resistance.
Date: November 16, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W248,
Rockville, Maryland 20850, 240–276–5085,
tandlea@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Assay
Validation of High-Quality Markers for
Clinical Studies in Cancer (UH2/UH3).
Date: November 17, 2021.
Time: 10:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W244, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: John Paul Cairns, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244,
Rockville, Maryland 20850, 240–276–5415,
paul.cairns@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI U01
Review: Integrating Biospecimen Science
Approaches into Clinical Assay.
Date: November 18, 2021.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute at Shady
Grove, 9609 Medical Center Drive, Room
7W116, Rockville, Maryland 20850
(Telephone Conference Call).
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
46709
Contact Person: Klaus B. Piontek, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W116,
Rockville, Maryland 20850, 240–276–5413,
klaus.piontek@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 16, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17820 Filed 8–18–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; ESTEEMED
Research Education Experiences (R25)
Program Review SEP.
Date: November 4, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Bethesda, MD 20892, (301)
451–4794, dennis.hlasta@nih.gov.
E:\FR\FM\19AUN1.SGM
19AUN1
46710
Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 NCBIB Review
C–SEP.
Date: November 8–10, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy Plaza,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Blvd., Suite 959, Bethesda, MD
20892, (301) 451–3397, sukharem@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, National Institute of
Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated:August 13, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–17748 Filed 8–18–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Geological Survey
[GX20EG31DW50100; OMB Control Number
1028–NEW]
Agency Information Collection
Activities; Submission to the Office of
Management and Budget for Review
and Approval; Hydrography
Addressing Tool
U.S. Geological Survey,
Interior.
ACTION: Notice of information collection;
request for comment.
lotter on DSK11XQN23PROD with NOTICES1
AGENCY:
SUMMARY: In accordance with the
Paperwork Reduction Act of 1995 (PRA,
44 U.S.C. 3501 et seq.), we, the U.S.
Geological Survey (USGS) are proposing
a new information collection.
DATES: Interested persons are invited to
submit comments on or before
September 20, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Please provide a copy
of your comments to U.S. Geological
Survey, Information Collections Officer,
12201 Sunrise Valley Drive MS 159,
Reston, VA 20192; or by email to gsinfo_collections@usgs.gov. Please
VerDate Sep<11>2014
17:28 Aug 18, 2021
Jkt 253001
reference OMB Control Number 1028–
NEW in the subject line of your
comments.
FOR FURTHER INFORMATION CONTACT: To
request additional information about
this ICR, contact Michael Tinker by
email at mdtinker@usgs.gov, or by
telephone at 303–202–4476. You may
also view the ICR at https://
www.reginfo.gov/public/do/PRAMain.
Individuals who are hearing or speech
impaired may call the Federal Relay
Service at 1–800–877–8339 for TTY
assistance.
SUPPLEMENTARY INFORMATION: In
accordance with the PRA and 5 CFR
1320.8(d)(1), we provide the general
public and other Federal agencies with
an opportunity to comment on new,
proposed, revised, and continuing
collections of information. This helps us
assess the impact of our information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand our
information collection requirements and
provide the requested data in the
desired format.
A Federal Register notice with a 60day public comment period soliciting
comments on this collection of
information was published on February
3, 2021, (86 FR 8030). No comments
were received.
As part of our continuing effort to
reduce paperwork and respondent
burdens, we are again soliciting
comments from the public and other
Federal agencies on the proposed ICR
that is described below. We are
especially interested in public comment
addressing the following:
(1) Whether or not the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether or not the
information will have practical utility;
(2) The accuracy of our estimate of the
burden for this collection of
information, including the validity of
the methodology and assumptions used;
(3) Ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) How might the agency minimize
the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of response.
Comments that you submit in
response to this notice are a matter of
public record. Before including your
address, phone number, email address,
or other personal identifying
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
information in your comment, you
should be aware that your entire
comment—including your personal
identifying information may be made
publicly available at any time. While
you can ask us in your comment to
withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Abstract
The Hydrography Addressing Tool
(HydroAdd) is a web tool built by the
USGS National Geospatial Program
(NGP). HydroAdd will support users by
providing a mechanism for referencing,
or addressing, diverse external datasets
to the National Hydrography Dataset
(NHD). As an example, a user could use
HydroAdd to reference the geographic
locations and other details of field
observations of fish presence to the
NHD. HydroAdd will provide a
framework for the management of
addressed data, as well as enable
upstream and down-stream analyses
within the context of the stream
network itself. Any type of information
could be addressed to the stream
network in this way, making this tool
highly useful for a broad range of
purposes that benefit the Nation.
HydroAdd users will be Federal
employees, such as USGS or other
Department of the Interior (DOI)
employees; or members of the public,
such as state, local, private sector,
academic, or other users with
knowledge of GIS and knowledge of
how to create a web feature service.
HydroAdd allows users to edit the
geometry of the features in their web
feature services to be coincident with
NHD features. Users cannot edit the
NHD with HydroAdd as it is displayed
in the application as a read-only
reference layer. Users must make their
own datasets available to HydroAdd as
a web feature service, either from their
own server hardware or from a thirdparty service, and all edits take place in
their own web feature service.
To use HydroAdd, users must register
a user account profile which contains
their business email and username. This
information is stored in the application
database. A user’s profile is visible only
to themselves and by HydroAdd
administrators. HydroAdd
administrators are a limited group of
USGS staff. User accounts are important
because they enable HydroAdd
administrators to contact and help the
user if needed, help to protect the user’s
data from edit by anyone who is not the
user, and enable tracking on the editing
history for the datasets through
reporting.
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 86, Number 158 (Thursday, August 19, 2021)]
[Notices]
[Pages 46709-46710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17748]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Institute
of Biomedical Imaging and Bioengineering Special Emphasis Panel.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; ESTEEMED Research Education
Experiences (R25) Program Review SEP.
Date: November 4, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Boulevard, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Hlasta, Ph.D., Scientific Review Officer,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD
20892, (301) 451-4794, [email protected].
[[Page 46710]]
Name of Committee: National Institute of Biomedical Imaging and
Bioengineering Special Emphasis Panel; P41 NCBIB Review C-SEP.
Date: November 8-10, 2021.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Two Democracy Plaza, 6707
Democracy Plaza, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manana Sukhareva, Ph.D., Scientific Review
Officer, National Institute of Biomedical Imaging and
Bioengineering, National Institutes of Health, 6707 Democracy Blvd.,
Suite 959, Bethesda, MD 20892, (301) 451-3397,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866,
National Institute of Biomedical Imaging and Bioengineering,
National Institutes of Health, HHS)
Dated:August 13, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-17748 Filed 8-18-21; 8:45 am]
BILLING CODE 4140-01-P
